Frazier Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Frazier Financial Advisors's BMY Position: Q2 2026 in Review
Frazier Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2026, selling an estimated $746 and leaving 883 shares worth $50.9K. The position accounts for 0.03% of the portfolio, ranked #183.
Frazier Financial Advisors first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $54.3K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Frazier Financial Advisors held 883 shares of Bristol-Myers Squibb worth $50.9K as of Q2 2026.
- Frazier Financial Advisors sold 13 Bristol-Myers Squibb shares in Q2 2026, an estimated $746.
- Bristol-Myers Squibb made up 0.03% of Frazier Financial Advisors's portfolio in Q2 2026, its #183 holding.
- Frazier Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Frazier Financial Advisors's Bristol-Myers Squibb position peaked at $54.3K in Q1 2026.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.